SCHEMBL4455953

SCHEMBL4455953

C=CC(=O)NCCOC(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC20 Q5W0Z9 1/20 0.48
ZDHHC2 Q9UIJ5 1/20 0.48
ALDH1A1 P00352 7/20 0.46
TSHR P16473 5/20 0.46
MAPK1 P28482 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 1/20 0.40
TGM2 P21980 2/20 0.39
CHRM5 P08912 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM3 P20309 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PGR P06401 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
HTR1A P08908 1/20 0.38
CHRNB2 P17787 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20146719 0.89 ZDHHC20 (0.55) ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1
SCHEMBL2612180 0.87 ZDHHC20 (0.58) ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1
SCHEMBL9485045 0.85 ZDHHC20 (0.61) ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1
SCHEMBL18856200 0.84 ZDHHC20 (0.39) ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1
SCHEMBL16803244 0.83 TSHR (0.50) ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1
SCHEMBL8331199 0.83 KMT2A (0.41) ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1
SCHEMBL490620 0.83 ZDHHC20 (0.44) ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1
SCHEMBL3818410 0.83 THRB (0.46) ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1
SCHEMBL2608182 0.82 ZDHHC20 (0.47) ZDHHC20ZDHHC2ALDH1A1TSHRMAPK1
SCHEMBL22813079 0.82 MEN1 (0.42) ALDH1A1TSHRMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12611384-B2 Antimicrobial nanoworms THE BOEING COMPANY (US) 2026-04-28 US claimed
CN-114555654-B Antimicrobial nanoworms 波音公司 2024-03-15 CN claimed
US-20220331262-A1 ANTIMICROBIAL NANOWORMS THE BOEING COMPANY 2022-10-20 US claimed
EP-4028435-A1 ANTIMICROBIAL NANOWORMS The Boeing Company (US) 2022-07-20 EP claimed
CN-114555654-A Antimicrobial nano-worms 波音公司 2022-05-27 CN claimed
EP-3778039-B1 DIGITAL PRINTING INKS SUN CHEMICAL CORP (US) 2022-04-06 EP claimed
EP-3110893-B1 DIGITAL PRINTING INKS SUN CHEMICAL CORP (US) 2020-12-23 EP claimed
US-12611384-B2 Antimicrobial nanoworms THE BOEING COMPANY (US) 2026-04-28 US disclosed
US-12247136-B2 Polymer dispersion having improved adhesion and wettability and methods for the same THE BOEING COMPANY (US) 2025-03-11 US disclosed
CN-118027299-A Antimicrobial Nanoworms 波音公司 2024-05-14 CN disclosed
CN-114555654-B Antimicrobial nanoworms 波音公司 2024-03-15 CN disclosed
US-20230135413-A1 CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY RICOH COMPANY, LTD. (JP) 2023-05-04 US disclosed
US-20230135413-A1 CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED COMPOSITION, ACTIVE-ENERGY-RAY-CURABLE WATER-BASED INK, STORED CONTAINER, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING APPARATUS, TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE FORMING METHOD, CURED PRODUCT, AND DECORATED BODY RICOH COMPANY, LTD. (JP) 2023-05-04 US disclosed
US-6900158-B2 High-molecular weight gel and display device FUJI PHOTO FILM CO., LTD. (JP) 2005-05-31 US disclosed
US-20040234906-A1 high sensitivity with a low degree of fogging and is excellent in raw stock storability and print-out resistance of images; contains: a compound having an adsorption group to silver halide and a reducing group, or a precursor of the compound; and a development accelerator FUJIFILM CORPORATION (JP) 2004-11-25 US disclosed
EP-1441254-A1 Photothermographic material FUJI PHOTO FILM CO., LTD. (JP) 2004-07-28 EP disclosed
US-20030203817-A1 High-molecular weight gel and display device FUJI PHOTO FILM CO., LTD. 2003-10-30 US disclosed
EP-0586974-B1 Silver halide colour photographic material AGFA GEVAERT AG (DE) 1998-12-09 EP disclosed
US-5441861-A Contains color coupler distributed in a polymeric oil former and a bisphenol compound; improved color stability AGFA-GEVAERT AB (DE) 1995-08-15 US disclosed
EP-0586974-A1 Silver halide colour photographic material AGFA-GEVAERT AG (DE) 1994-03-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220331262-A1 ANTIMICROBIAL NANOWORMS DNPEP, MGAM, MASP2 ZDHHC20 3391/4885ZDHHC2 4377/4885ALDH1A1 1183/4885
US-12247136-B2 Polymer dispersion having improved adhesion and wettability and methods for the same CLTA, ICAM1, CLTC ZDHHC20 3561/4885ZDHHC2 4336/4885ALDH1A1 2184/4885
US-12611384-B2 Antimicrobial nanoworms LCT, DNPEP, CLTA ZDHHC20 3690/4885ZDHHC2 4430/4885ALDH1A1 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.